Piramal Pharma Ltd. Market Research Report

Company Overview

Name:

Piramal Pharma Ltd.

Mission of the Company:

No information is available.

Founding Details:

• Founded: 1998, initially through a joint venture with Boots Plc.

• Acquired its independent entity in 2008.

Founders:

No specific founding individuals mentioned.

Key People:

• Nandini Piramal, Chairperson

• Nitish Bajaj, CEO of the Consumer Products Division

Headquarters:

Mumbai, India

Number of Employees:

No information is available.

Revenue:

• Ended FY 2020 with a topline value of Rs. 420 Crores.

• Expected turnover for the consumer healthcare business approximately ₹1,000 crore from ₹800 crore in the previous fiscal year.

Known For:

Piramal Pharma Ltd. is known for its robust presence in the domestic consumer healthcare market, with a focus on over-the-counter (OTC) consumer products across various categories.

Products

Overview:

Piramal Pharma Ltd. has a diversified portfolio containing over 21 brands spread across several key categories including skin care, antacids, digestives, women intimate range, kids' wellbeing & baby care, pain management, oral care, gut health, respiratory products, multivitamins, and food supplements.

Key Products:

1. Polycrol:

• Fast relief from acidity.

• Market leader in the liquid antacid segment in Eastern India.

2. Lacto Calamine:

• Comprehensive skin care range that includes oil control lotion, face wash, and sunscreen.

• Offers oil-free and clear matte skin.

3. Tetmosol:

• Medicated skin-care soap for treating and preventing skin infections.

• Associated with celebrities like Ajay Devgn to promote products including Tetmosol Dusting Powder.

4. i-know:

• An ovulation test kit that detects the LH surge in women.

• Category creator being the first in the Indian market.

5. Little's Baby Care Range:

• Trusted baby care brand with products for children aged 0 to 4 years.

• Known for its quality and trustworthiness among Indian mothers.

6. i-pill:

• Emergency contraceptive pill launched in 2007.

• Preferred brand in its category.

High-Level Descriptions:

• Each product line features a unique position in the market, addressing specific consumer needs like skincare, digestive health, and women’s intimate health.

• The brands leverage long-standing market presence and consumer trust, with several products achieving market-leading status in their categories.

Recent Developments

Product Launches and Expansion:

• 2024: Launched a media campaign for Lacto Calamine Sunscreen and Facewash in Karnataka.

• 2023: Polycrol launched chewable tablets; expansion of Lacto Calamine with new products.

• 2022: Expanded Lacto Calamine skin care with new products like charcoal peel-off mask and sunscreen.

• 2021: Tetmosol appointed Ajay Devgn as the brand ambassador; lacto calamine became a top-ranking product on Amazon.

Partnerships and Acquisitions:

• Acquired Nixit in 2023 and launched Nixit Gums.

• Hemmo Pharmaceuticals acquisition for Rs. 775 crore and a 27.78% stake in Yapan Bio.

Economic and Strategic Initiatives:

• Plan to invest ₹1,000 crore into expanding operations over 18 months focusing on revenue gain and operational excellence.

• Raised ₹1,050 crore through a rights issue for debt reduction and expansion.

• Focusing on sustainable growth across its CDMO, CHG, and consumer healthcare divisions.

Media and Advertising:

• Engaged high-profile brand ambassadors such as Ajay Devgn and Amyra Dastur to promote its brands.

• Innovative consumer campaigns, including digital marketing efforts and expansion into e-commerce channels.

Market Position:

• Operating in more than 1500 towns with a direct presence in ~250K outlets.

• Aim to achieve the #3 position in the Indian OTC market.

Note: All information provided is based on the extracted data and might not encompass all recent developments or market activities.